University of Illinois at Chicago
Announcement of an Emergency Award/Quick Purchase
Vendor: Genzyme Corporation
Final Amount: $0
Patient insurance complications prevented the purchase and alternative therapy was provided to the patient. No expenditure.
The State Purchasing Officer for this procurement is now Lee Saulter.
The University award process may be delayed up to thirty days as this award goes through a state approval process.
Awarded to:Vendor: Genzyme Corporation, Cambridge, MA
Amount: An estimated $120,000
Terms:
An estimated start date of 10/29/2015 through 11/7/2015
Renewals:
None
The University award process may be delayed up to thirty days as this award goes through a state approval process.
First published Thursday, October 29, 2015
The University awarded a contract for purchase of an IV drug, Lemtrada from Genyzme.
This emergency/quick purchase was required due to a situation in which immediate action was needed to prevent any disruption in University services.
The University awarded a contract with Genzyme Corporation for the IV drug Lemtrada which was prescribed for an MS outpatient in the Pharmacy Clinic. Genzyme is the manufacturer of this medication and direct purchase from Genzyme is the only method to obtain the product. They have no resellers or distributors. The cost is $19,750 per dose with most patients receiving 5 doses per course of therapy. A second course of therapy could be required one year later, depending on patient response, consisting of 3 additional doses.
This emergency purchase was made as the patient will be administered the IV drug immediately. A sole source (607JCM) request is pending which will provide authority for future purchases.
For additional information, contact:
State Purchasing Officer - Gary Reis
This transaction is subject to the State Board of Elections registration and certification requirements of Public Act 095-0971.
The State of Illinois has a policy to encourage prospective vendors to hire
qualified veterans, minorities, females, persons with disabilities and ex-offenders.
